CA2158425A1 - Diagnostic et traitement pour les dysfonctions erectiles - Google Patents

Diagnostic et traitement pour les dysfonctions erectiles

Info

Publication number
CA2158425A1
CA2158425A1 CA002158425A CA2158425A CA2158425A1 CA 2158425 A1 CA2158425 A1 CA 2158425A1 CA 002158425 A CA002158425 A CA 002158425A CA 2158425 A CA2158425 A CA 2158425A CA 2158425 A1 CA2158425 A1 CA 2158425A1
Authority
CA
Canada
Prior art keywords
treatment
diagnostic
erectile dysfunction
peptides
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002158425A
Other languages
English (en)
Other versions
CA2158425C (fr
Inventor
Mac E. Hadley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Competitive Technologies Inc
Original Assignee
Competitive Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Competitive Technologies Inc filed Critical Competitive Technologies Inc
Priority to CA002158425A priority Critical patent/CA2158425C/fr
Publication of CA2158425A1 publication Critical patent/CA2158425A1/fr
Application granted granted Critical
Publication of CA2158425C publication Critical patent/CA2158425C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CA002158425A 1995-09-15 1995-09-15 Diagnostic et traitement pour les dysfonctions erectiles Expired - Lifetime CA2158425C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002158425A CA2158425C (fr) 1995-09-15 1995-09-15 Diagnostic et traitement pour les dysfonctions erectiles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002158425A CA2158425C (fr) 1995-09-15 1995-09-15 Diagnostic et traitement pour les dysfonctions erectiles

Publications (2)

Publication Number Publication Date
CA2158425A1 true CA2158425A1 (fr) 1997-03-16
CA2158425C CA2158425C (fr) 2003-01-28

Family

ID=4156606

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002158425A Expired - Lifetime CA2158425C (fr) 1995-09-15 1995-09-15 Diagnostic et traitement pour les dysfonctions erectiles

Country Status (1)

Country Link
CA (1) CA2158425C (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034171A2 (fr) * 1999-11-10 2001-05-17 Zentaris Ag Peptides destines au traitement de la dyserection
US8455618B2 (en) 2009-06-08 2013-06-04 Astrazeneca Ab Melanocortin receptor-specific peptides
US8492517B2 (en) 2009-11-23 2013-07-23 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152079A1 (fr) 2008-06-09 2009-12-17 Palatin Technologies, Inc. Peptides spécifiques du récepteur de mélanocortine pour le traitement d'un dysfonctionnement sexuel
CA2781405A1 (fr) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Peptides lineaires specifiques du recepteur de la melanocortine-1

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034171A2 (fr) * 1999-11-10 2001-05-17 Zentaris Ag Peptides destines au traitement de la dyserection
WO2001034171A3 (fr) * 1999-11-10 2001-12-13 Zentaris Ag Peptides destines au traitement de la dyserection
US8455618B2 (en) 2009-06-08 2013-06-04 Astrazeneca Ab Melanocortin receptor-specific peptides
US8455617B2 (en) 2009-06-08 2013-06-04 Astrazeneca Ab Melanocortin receptor-specific peptides
US9040663B2 (en) 2009-06-08 2015-05-26 Astrazeneca Ab Melanocortin receptor-specific peptides
US8492517B2 (en) 2009-11-23 2013-07-23 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
US8877890B2 (en) 2009-11-23 2014-11-04 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
US9447148B2 (en) 2009-11-23 2016-09-20 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
US10711039B2 (en) 2009-11-23 2020-07-14 Palatin Technologies, Inc. Melanocortin receptor-specific peptide with C-terminal naphthylalanine

Also Published As

Publication number Publication date
CA2158425C (fr) 2003-01-28

Similar Documents

Publication Publication Date Title
EA199700213A1 (ru) Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений
AU2295895A (en) Dosage forms and method for ameliorating male erectile dysfunction
EP0831832A4 (fr) Procedes pour lutter contre des maladies infectieuses a l'aide de bis-benzimidazoles dicationiques
EP1027057A4 (fr) Traitement du dysfonctionnement sexuel chez la femme
AU6915396A (en) Multiple sclerosis treatment
CA2130778A1 (fr) Orthese penienne permettant l'erection
HU9603469D0 (en) Pyrazolo and pyrrolopyridines
AU2562797A (en) Combination therapy for treatment of erectile dysfunction
PL310476A1 (en) Application of lamotrigin in treating neuro-aids diseases
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
IT1264965B1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
GB2380939B (en) Treatment or prevention of auto-immune diseases
CA2342830A1 (fr) Pyrazolo[4,3-d]-pyrimidin-7-ones 5-heterocyclyle, servant au traitement des troubles de l'erection chez l'homme
CA2158425A1 (fr) Diagnostic et traitement pour les dysfonctions erectiles
MY133446A (en) Treatment of impotence due to spinal cord injury
MX9805506A (es) Uso medico novedoso de un inhibidor de la dispepsia relacionada con acido para el tratamiento de sintomas dispepticos.
AU4676099A (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
MX9803610A (es) Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico.
WO1997026880A3 (fr) Utilisation d'une combinaison de delavirdine et d'un ou plusieurs inhibiteurs de protease chez des patients contamines par le vih-1
BG103859A (en) The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions
AU7078298A (en) Method for the diagnosis, treatment and prophylaxis of premature ejaculation andcatheter for the diagnosis, treatment and prophylaxis of premature ejaculation
AU4390597A (en) Combination therapy for treatment of arthritic diseases
MD518G2 (ro) Remediu pentru sporirea rezistenţei organismului uman
GB2318057A (en) Treatment of nocturnal polyuria using an ace inhibitor in combination with a diuretic

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150915